Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer
- PMID: 29386089
- PMCID: PMC7844703
- DOI: 10.3727/096504018X15166193231711
Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer
Retraction in
-
Retraction: Long noncoding RNA GAS5 promotes proliferation, migration, and invasion by regulation of miR-301a in esophageal cancer.Oncol Res. 2024 Oct 16;32(11):1823. doi: 10.32604/or.2024.056896. eCollection 2024. Oncol Res. 2024. PMID: 39449810 Free PMC article.
Abstract
Long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been revealed to be associated with the progression of various cancers. However, the biological roles of GAS5 in esophageal cancer (EC) remain unclear. We aimed to thoroughly explore the functions of GAS5 in EC. The results showed that GAS5 expression was increased in EC cells (ECA109, TE-1, TE-3, and EC9706) compared to SHEE cells. Knockdown of GAS5 decreased cell viability, migration, and invasion and induced apoptosis in EC9706 cells. Moreover, miR-301a appeared to be directly sponged by GAS5, and miR-301a suppression obviously alleviated the protumor effects of GAS5. Furthermore, miR-301a positively regulated CXCR4 expression, and overexpression of CXCR4 induced apoptosis and abolished the promoting effect of miR-301a inhibition on cell viability, migration, and invasion. Besides, miR-301a blocked Wnt/β-catenin and NF-κB signaling pathways by regulation of CXCR4. Our results indicated that GAS5 promoted proliferation and metastasis and inhibited apoptosis by regulation of miR-301a in EC. These data contributed to our understanding of the mechanisms of miRNA-lncRNA interaction and provides a novel therapeutic strategy for EC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: Current management of esophageal cancer. J Gastrointest Surg. 2015;19(5):964–72. - PubMed
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095–128. - PMC - PubMed
-
- Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, Mir A, Lashkari M, Zendehdel K. Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. Dig Surg. 2013;30(4–5):331–6. - PubMed
-
- Aghajanzadeh M, Rahimi A, Emami D, Aghajanzadeh G, Jahromi SK, Ebrahimi H. A comparison of survival with chemoradiation therapy alone versus surgery and post-esophagectomy chemoradiation in patients with esophageal carcinoma. Nishinihon J Urol. 2014;2(4):350–2.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical